Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page
- Check7 days agoChange DetectedAdded a resource entry for Multiple myeloma linking to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check28 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page shows a revision update from v3.4.1 to v3.4.2; no changes to study content or core functionality are evident.SummaryDifference0.1%

- Check64 days agoChange DetectedA minor site version update from v3.4.0 to v3.4.1 is applied with no observed user-facing changes to the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedShow glossary control added and page revision updated to v3.4.0. Metadata labels were adjusted, including Last Update Submitted that Met QC Criteria and No FEAR Act data.SummaryDifference0.2%

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.